<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cancer Treatments on FinanClub</title>
    <link>https://finan.club/tags/cancer-treatments/</link>
    <description>Recent content in Cancer Treatments on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 08 Aug 2023 07:17:02 +0000</lastBuildDate><atom:link href="https://finan.club/tags/cancer-treatments/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title> GILD</title>
      <link>https://finan.club/us/gild/</link>
      <pubDate>Tue, 08 Aug 2023 07:17:02 +0000</pubDate>
      
      <guid>https://finan.club/us/gild/</guid>
      <description>score:724
Chances: Gilead Sciences expects a third of sales to come from its cancer treatments by 2030, driving optimism and stock price movement. Gilead Sciences is focused on developing therapies for life-threatening infectious diseases and expanding its portfolio to include pulmonary, cardiovascular diseases, and cancer treatments.</description>
    </item>
    
  </channel>
</rss>
